Bright Minds Biosciences (DRUG) Cost of Revenue (2020 - 2026)
Bright Minds Biosciences (DRUG) reported Cost of Revenue of $30978.8 for Q1 2026, down 60.61% on a YoY basis from $78639.4 in Q1 2025, and down 71.99% quarter-over-quarter from $110585.5 in Q4 2025.
Bright Minds Biosciences (DRUG) Cost of Revenue (2020 - 2026) Analysis & Trends
Bright Minds Biosciences has reported Cost of Revenue for 7 years, with the latest figure at $30978.8 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 64.20 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 48,670.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 392.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 2.05 Mn |
| 10 | Bright Minds Biosciences | 16.42 Bn | 16.36 Bn | - | 30,978.85 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30,978.85 |
| Mar 31, 2026 | 30,978.85 |
| Dec 31, 2025 | 110,585.46 |
| Dec 31, 2025 | 110,585.46 |
| Jun 30, 2025 | 9,035.84 |
| Jun 30, 2025 | 9,035.84 |
| Mar 31, 2025 | 78,639.36 |
| Mar 31, 2025 | 78,639.36 |
| Dec 31, 2024 | 27,456.39 |
| Dec 31, 2024 | 27,456.39 |
| Jun 30, 2024 | 8,307.95 |
| Jun 30, 2024 | 8,307.95 |
| Mar 31, 2024 | 66,261.06 |
| Mar 31, 2024 | 66,261.06 |
| Dec 31, 2023 | 53,101.78 |
| Dec 31, 2023 | 53,101.78 |
| Jun 30, 2023 | 12,794.16 |
| Jun 30, 2023 | 12,794.16 |
| Mar 31, 2023 | 68,856.86 |
| Mar 31, 2023 | 68,856.86 |